TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Bioform AS
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
21,268
|
11,852
|
14,665 |
Financial expenses |
137
|
131
|
33 |
Earnings before taxes |
8,664
|
759
|
4,163 |
Total assets |
20,654
|
16,480
|
14,139 |
Current assets |
17,113
|
14,120
|
12,511 |
Current liabilities |
2,059
|
4,902
|
3,302 |
Equity capital |
18,595
|
11,579
|
10,837 |
- share capital |
700
![]() |
700
![]() |
700 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
90.0%
|
70.3%
|
76.6% |
Turnover per employee | |||
Profit as a percentage of turnover |
40.7%
|
6.4%
|
28.4% |
Return on assets (ROA) |
42.6%
|
5.4%
|
29.7% |
Current ratio |
831.1%
|
288.0%
|
378.9% |
Return on equity (ROE) |
46.6%
|
6.6%
|
38.4% |
Change turnover |
9,416
|
-2,813
|
7,194 |
Change turnover % |
79%
|
-19%
|
96% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.